Brief: 180 Life Sciences Expands Scientific Fibrosis Platform With Collagen Vi As A Driver And Disease Biomarker In Human Fibrosis Published In The Febs Journal
07/07/2021 13:13
July 7 (Reuters) - 180 Life Sciences Corp ATNF.O :
* 180 LIFE SCIENCES EXPANDS SCIENTIFIC FIBROSIS PLATFORM
WITH
COLLAGEN VI AS A DRIVER AND DISEASE BIOMARKER IN HUMAN FIBROSIS
PUBLISHED IN THE FEBS JOURNAL
Source text for Eikon: ID:nGNX1wKzYF
Further company coverage: ATNF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Forum Markets
See all newsForum Markets, Inc reports results for the quarter ended June 30 - Earnings Summary
Forum Markets Q2 revenue falls on digital asset exit
Forum Markets, Inc expected to post a loss of 26 cents a share - Earnings Preview
Forum Markets, Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Forum Markets, Inc - To Deploy Capital Into Ai Chip Bridge Loans For Nvidia Gpu Purchases